Among these three genes, patients with mutations in CDH10, a cadherin which is predominantly expressed in brain [11], displayed a significant association with poor survival, after adjusting for age, gender, tumor stage, and chemotherapy status (p = 0.0127). The gene discussed is CDH17; the disease is neoplasm.